In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant Enterococci

被引：17

作者：

Messick, CR ^{[1
]}

Pendland, SL ^{[1
]}

机构：

[1] UNIV ILLINOIS,COLL PHARM,DEPT PHARM PRACTICE,CHICAGO,IL 60612

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 1997年 / 29卷 / 03期

关键词：

D O I：

10.1016/S0732-8893(97)81811-1

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Using a checkerboard assay, ampicillin, vancomycin, and XP 59500, each in combination with chloramphenicol, were tested for synergy against 23 isolates of vancomycin-resistant enterococci. Additive effects were seen in 62.5% of the isolates when exposed to chloramphenicol pins RP 59500. Additive effects were observed in 20% and 15% of isolates with chloramphenicol plus vancomycin or ampicillin, respectively. Na antagonism was noted. (C) 1997 Elsevier Science Inc.

引用

页码：203 / 205

页数：3

共 14 条

[1]

Eliopolous GM., 1996, Antibiotics in laboratory medicine, P330

[2] IN-VITRO ACTIVITY OF RP-59500 (QUINUPRISTIN DALFOPRISTIN) AGAINST ANTIBIOTIC-RESISTANT STRAINS OF STREPTOCOCCUS-PNEUMONIAE AND ENTEROCOCCI [J].

JOHNSON, CC ;

SLAVOSKI, L ;

SCHWARTZ, M ;

MAY, P ;

PITSAKIS, PG ;

SHUR, AL ;

LEVISON, ME .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 21 (03) :169-173

[3] PHARMACODYNAMICS OF RP-59500 ALONE AND IN COMBINATION WITH VANCOMYCIN AGAINST STAPHYLOCOCCUS-AUREUS IN AN IN VITRO-INFECTED FIBRIN CLOT MODEL [J].

KANG, SL ;

RYBAK, MJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1505-1511

[4] THE CHALLENGE OF VANCOMYCIN-RESISTANT ENTEROCOCCI - A CLINICAL AND EPIDEMIOLOGY STUDY [J].

LAM, S ;

SINGER, C ;

TUCCI, V ;

MORTHLAND, VH ;

PFALLER, MA ;

ISENBERG, HD .

AMERICAN JOURNAL OF INFECTION CONTROL, 1995, 23 (03) :170-180

[5] INVITRO COMPARISON OF AMPICILLIN-CHLORAMPHENICOL AND AMPICILLIN-CEFOTAXIME AGAINST 284 HAEMOPHILUS ISOLATES [J].

LAPOINTE, JR ;

LAVALLEE, C ;

MICHAUD, A ;

CHICOINE, L ;

JONCAS, JH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (04) :594-597

[6]

*NAT COMM CLIN LAB, 1995, M100S6 NCCLS, V15

[7]

National Committee for Clinical Laboratory Standards, 1993, M7A3 NCCLS, V13

[8] CHLORAMPHENICOL FOR THE TREATMENT OF VANCOMYCIN-RESISTANT ENTEROCOCCAL INFECTIONS [J].

NORRIS, AH ;

REILLY, JP ;

EDELSTEIN, PH ;

BRENNAN, PJ ;

SCHUSTER, MG .

CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) :1137-1144

[9]

RICE LB, 1994, 34 INT C ANT AG CHEM, P221

[10] CHLORAMPHENICOL INHIBITION OF THE BACTERICIDAL EFFECT OF AMPICILLIN AGAINST HEMOPHILUS-INFLUENZAE [J].

ROCCO, V ;

OVERTURF, G .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (02) :349-351

← 1 2 →